Table 1 Clinical characteristics of COVID-19 patients involved in this study
Characteristics | Total (N = 352) N (%); mean ± SD | Delta variant (N = 213) N (%); mean ± SD | Omicron variant (N = 139) N (%); mean ± SD | p-value |
|---|---|---|---|---|
Ct value | 20.42 ± 3.95 | 20.36 ± 4.07 | 20.5 ± 3.76 | 0.146 |
Age (years) | 37.53 ± 21.23 | 36.53 ± 21.24 | 39.06 ± 21.24 | 0.273 |
 ≥ 65 | 36 (10.2%) | 20 (9.4%) | 16 (11.5%) |  |
 18 - <65 | 235 (66.8%) | 140 (65.7%) | 95 (68.3%) |  |
 < 18 | 81 (23%) | 53 (24.9%) | 28 (20.1%) |  |
Sex | Â | Â | Â | 0.072 |
 Male | 164 (46.6%) | 91 (42.7%) | 73 (52.5%) |  |
 Female | 188 (53.4%) | 122 (57.3%) | 66 (47.5%) |  |
Comorbidities | Â | Â | Â | Â |
 Obesity | 4 (1.1%) | 4 (1.9%) | 0 (0%) | 0.156 |
 Diabetes | 29 (8.2%) | 23 (10.8%) | 6 (4.3%) | 0.031* |
 Hypertension | 35 (9.9%) | 24 (11.3%) | 11 (7.9%) | 0.304 |
 Cardiovascular disease | 23 (6.5%) | 12 (5.6%) | 11 (7.9%) | 0.398 |
 Chronic kidney disease | 7 (2%) | 1 (0.5%) | 6 (4.3%) | 0.017* |
Smoking | 17 (4.8%) | 12 (5.6%) | 5 (3.6%) | 0.384 |